July 2 (Reuters) - Sigma Pharmaceuticals Ltd SIP.AX :
* No charges have been laid against the company or current or former executives or non-executive directors of the company
* Matter will have no impact on Sigma's ongoing business
* ASIC announced Elmo De Alwis, former MD, CEO of Sigma, and Mark Smith, former CFO of Sigma, pleaded guilty to charges relating to falsifying co's books
* Charges follow ASIC investigation, relate to their conduct in accounting for four financial transactions between June 2009 and March 2010
* Source text for Eikon ID:nASX4M9FZK